- Conditions
- Respiratory Syncytial Virus Immunization
- Interventions
- RSV vaccine candiate formulation 1, RSV vaccine candidate formulation 2, Placebo
- Biological · Other
- Lead sponsor
- Sanofi Pasteur, a Sanofi Company
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 865 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2025
- U.S. locations
- 25
- States / cities
- Huntsville, Alabama • Mesa, Arizona • Peoria, Arizona + 22 more
Source: ClinicalTrials.gov public record
Updated May 30, 2025 · Synced May 21, 2026, 10:10 PM EDT